Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid

Neuroscience

Volumn 152, Issue 2, 2008, Pages 296-298

  Inoue, M ^a   Xie, W ^a   Matsushita, Y ^a   Chun, J ^b   Aoki, J ^c   Ueda, H ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

autotaxin; biosynthesis; LPA; LPA1 receptor; LPC; neuropathic pain

Indexed keywords

AUTOTAXIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEMYELINATION; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; PAIN MEASUREMENT; PHOSPHODIESTERASE I; PYROPHOSPHATASES; REACTION TIME; RECEPTORS, LYSOPHOSPHATIDIC ACID; TIME FACTORS;

EID: 40849140705     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.12.041     Document Type: Article

References (21)

1. Aoki J. Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol 15 (2004) 477-489
2. Boerkoel C.F., Takashima H., Stankiewicz P., Garcia C.A., Leber S.M., Rhee-Morris L., and Lupski J.R. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 68 (2001) 325-333
3. Carter G.T., Jensen M.P., Galer B.S., Kraft G.H., Crabtree L.D., Beardsley R.M., Abresch R.T., and Bird T.D. Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 79 (1998) 1560-1564
4. Contos J.J., Fukushima N., Weiner J.A., Kaushal D., and Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci U S A 97 (2000) 13384-13389
5. Eder A.M., Sasagawa T., Mao M., Aoki J., and Mills G.B. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res 6 (2000) 2482-2491
6. Farooqui A.A., Ong W.Y., and Horrocks L.A. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58 (2006) 591-620
7. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67 (1980) 313-316
8. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., and Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10 (2004) 712-718
9. Jeffery N.D., and Blakemore W.F. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24 (1995) 775-781
10. Kotter M.R., Zhao C., van Rooijen N., and Franklin R.J. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18 (2005) 166-175
11. Meyer zu Heringdorf D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochimi Biophys Acta 1768 (2007) 923-940
12. Murugesan G., and Fox P.L. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest 97 (1996) 2736-2744
13. Ousman S.S., and David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21 (2001) 4649-4656
14. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., and Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 304 (2003) 940-948
15. Sato K., Malchinkhuu E., Muraki T., Ishikawa K., Hayashi K., Tosaka M., Mochiduki A., Inoue K., Tomura H., Mogi C., Nochi H., Tamoto K., and Okajima F. Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J Neurochem 92 (2005) 904-914
16. Shen Z., Belinson J., Morton R.E., Xu Y., and Xu Y. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol Oncol 71 (1998) 364-368
17. Tanaka M., Kishi Y., Takanezawa Y., Kakehi Y., Aoki J., and Arai H. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Lett 571 (2004) 197-204
18. Tanaka M., Okudaira S., Kishi Y., Ohkawa R., Iseki S., Ota M., Noji S., Yatomi Y., Aoki J., and Arai H. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281 (2006) 25822-25830
19. van Meeteren L.A., and Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46 (2007) 145-160
20. Wallace V.C., Cottrell D.F., Brophy P.J., and Fleetwood-Walker S.M. Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids. J Neurosci 23 (2003) 3221-3233
21. Yokota T., and Hansson G.K. Immunological mechanisms in atherosclerosis. J Intern Med 238 (1995) 479-489